Redefining pharmaceutical CRM
October 24, 2007Research and Development, Sales and Marketing CRM, customer relationship management, sales
Fierce generic competition, price containment regulations and poor pipeline productivity are challenges looming over many pharmaceutical companies today. In effect, …
Latest news from Datamonitor
October 24, 2007Research and Development
Abraxis gets FDA approval for chemotherapy drugAbraxis Pharmaceutical Products, the hospital-based business of Abraxis BioScience, has received FDA approval to …
Novartis changes pharma management after weak third quarter
October 19, 2007Sales and Marketing Novartis
Novartis has switched the heads of its consumer and pharmaceuticals divisions as part of a wider reorganisation of its pharma …
Genzyme expands UK presence
October 19, 2007Genzyme has opened its expanded UK headquarters in Oxford, underlining its rapid growth in the market.Andrew Smith, MP for Oxford …
New products behind Lilly growth
October 19, 2007Sales and Marketing lilly, zyprexa
Sales rose 19% for Lilly in the third quarter of the year, with depression treatment Cymbalta leading the growth in …
Pharma consultants on shortlist to help PCTs improve services
October 19, 2007Fourteen private companies have been awarded favoured supplier status to assist PCTs in their strategic planning and commissioning of services.The …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
Underperforming NHS trusts threatened with takeover
October 18, 2007Health secretary Alan Johnson has warned the worst performing trusts in the NHS that they could face a takeover from …
Latest news from Datamonitor
October 18, 2007Research and Development
Advaxis cancer vaccine shows encouraging resultsBiotechnology company Advaxis has announced positive results from a Phase I/II first-in-man trial of a …
NHS spending growth slows
October 12, 2007The government will increase its health budget by £20 billion over the next three years, but the current record levels …
Pfizer to set up separate biotech arm
October 11, 2007Research and Development
Pfizer has unveiled its new strategy in research and development, including senior appointments and the setting up of an independent …
Efficiency drive has saved NHS millions, say ministers
October 11, 2007New targets set for PCTs have saved the NHS millions, according to new figures released by the Department of Health.Health …
Eucreas a step nearer European approval
October 11, 2007Sales and Marketing
Novartis' new combination drug, Eucreas, is set for approval following recommendation from Europe's medicines regulator. Eucreas is a single-tablet combination …
Wyeth names new chief executive
October 10, 2007Sales and Marketing Pfizer, Wyeth
Wyeth will begin 2008 with a new leader at the helm. Bernard Poussot will become the company's elected president and …
Gates Foundation invests $100m in unorthodox research
October 10, 2007Research and Development
Scientists with novel ideas for research into some of the world's biggest diseases are to be offered a new source …
Latest news from Datamonitor
October 9, 2007Research and Development
Critical Therapeutics starts Phase I trial of zileutonCritical Therapeutics has initiated a phase I clinical trial to assess the safety …
Wyeth buys Scottish biotech firm
October 8, 2007Research and Development
Wyeth is to acquire Haptogen, a biotech research company based in Aberdeen which has a unique approach to targeting the …
GSK appoints Witty to top job
October 8, 2007Sales and Marketing
GlaxoSmithKline has named JP Garnier's successor when he steps down as chief executive at the end of May next year.Andrew …
100m boost for NHS innovation
October 8, 2007A new body has been set up to promote innovation across the NHS and pharmaceutical products will form a key …
Latest content
FibroFind appoints Lee Borthwick as CEO
